Role of resting-state functional MRI in detecting brain functional changes following radiotherapy for head and neck cancer: asystematic review and meta-analysis.

Abstract

Increasing evidence implicates changes in brain function following radiotherapy for head and neck cancer as precursors for brain dysfunction. These changes may thus be used as biomarkers for early detection. This review aimed to determine the role of resting-state functional magnetic resonance imaging (rs-fMRI) in detecting brain functional changes. Asystematic search was performed in the PubMed, Scopus, and Web of Science (WoS) databases in June 2022. Patients with head and neck cancer treated with radiotherapy and periodic rs-fMRI assessments were included. Ameta-analysis was performed to determine the potential of rs-fMRI for detecting brain changes. Ten studies with atotal of 513subjects (head and neck cancer patients, n = 437; healthy controls, n = 76) were included. Asignificance of rs-fMRI for detecting brain changes in the temporal and frontal lobes, cingulate cortex, and cuneus was demonstrated in most studies. These changes were reported to be associated with dose (6/10studies) and latency (4/10studies). Astrong effect size (r = 0.71, p < 0.001) between rs-fMRI and brain changes was also reported, suggesting rs-fMRI's capability for monitoring brain alterations. Resting-state functional MRI is apromising tool for detecting brain functional changes following head and neck radiotherapy. These changes are correlated with latency and prescription dose.